| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:77597814:1341 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:77597814:1341?format=raw |
LEADER: 01341mam a2200325 i 4500
001 4061805
005 20221027030046.0
008 990807s1999 sz a b 001 0 engsd
020 $a3805568967
035 $a(OCoLC)ocm42041873
035 $9APX8775HS
035 $a(NNC)4061805
035 $a4061805
040 $aOHX$bger$cOHX$dIWA$dNNC-M
072 7 $aQH$2lcco
090 $aQR189.5.I5$bI56x 1999
245 00 $aInactivated influenza vaccines prepared in cell culture :$bNational Institute for Biological Standards and Control, Potters Bar., Herts.,U.K. September 26-27, 1997 / volume editors, Fred Brown ... [et al.].
260 $aBasel :$bKarger,$c1999.
300 $aix, 209 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aDevelopments in biological standardization ;$v98
500 $aConference proceedings.
650 0 $aInfluenza vaccines$vCongresses.
650 0 $aInfluenza viruses$vCongresses.
650 12 $aInfluenza Vaccines.$0https://id.nlm.nih.gov/mesh/D007252
650 12 $aOrthomyxoviridae.$0https://id.nlm.nih.gov/mesh/D009975
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
830 0 $aDevelopments in biological standardization ;$vv. 98.$0http://id.loc.gov/authorities/names/n42009020
852 00 $boff,hsl$hQR189.5.I5$iI52 1999